4.3 Editorial Material

The STAR*D Trial: Revealing the Need for Better Treatments

期刊

PSYCHIATRIC SERVICES
卷 60, 期 11, 页码 1466-1467

出版社

AMER PSYCHIATRIC PUBLISHING, INC
DOI: 10.1176/ps.2009.60.11.1466

关键词

-

向作者/读者索取更多资源

STAR*D (Sequenced Treatment Alternatives to Relieve Depression) continues to stimulate debate. The landmark trial demonstrated the feasibility of large-scale, community-based studies conducted without pharmaceutical company support. The results provided insight into nonresponse to initial treatment with selective serotonin reuptake inhibitors and alternatives for second-and third-line treatment options and suggested opportunities for personalized approaches to depression care. However, initial and one-year remission rates (28% and 70%, respectively) suggest that important goals for treatment of this disabling disease remain out of reach and that the bar for antidepressants has been set far too low. (Psychiatric Services 60: 1466-1467, 2009)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据